respiratory drugs Flashcards

1
Q

what is asthma ?

A

chronic inflammatory disorder of the airway- caused by immune mediated immune inflammation

symptoms are a result of inflammation and bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

signs and symptoms of asthma ?

A

Sense of breathlessness
Tightening of the chest
Wheezing
Dyspnea
Cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is copd ?

A

chronic obstructive pulmonary disease - non reversible long term that can be characterize by air flow restrictions and inflammation
most often caused by cigarettes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

signs and symptoms of copd

A

Chronic cough
Excessive sputum production
Wheezing
Dyspnea
Poor exercise tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Patho of COPD

A

symptoms are mostly a result from chronic bronchitis and emphysema - which take place from an exagerated inflammatory response to smoke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is emphysema

A

enlargement of the air space within the bronchioles and alveoli brought on by the deterioration of these walls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

meds that are used for asthma and copd

A

glucococorticoids ( anti inflammatory agents
bronchodilators (beta 2 agonists )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

anti inflammatory drugs are

A

foundation of asthma treatment, taken for long term control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

mechanism of action of glucocorticoids?

A

Mechanism of action = suppress inflammation
Reduce bronchial hyperreactivity and decrease airway mucous production

Reduce infiltration and activity of inflammatory cells

Usually administered by inhalation, but IV and oral routes are also options

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

use of glucocortcoids

A

Prophylaxis of chronic asthma
Dosing must be on a fixed schedule, not as needed (PRN)
Not used to abort an ongoing attack because beneficial effects develop slowly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

glucocortcoids are considered :

A

the first line of therapy for for management of inflammatory component of asthma
- persistant asthma patients should use this daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

oral use of glucocorticoids

A

For patients with moderate to severe persistent asthma or for management of acute exacerbations of asthma or COPD
- should be used only when symptoms cannot be controlled with safer medications (inhaled glucocorticoids, inhaled beta2 agonists
Treatment should be as brief as possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

adverse effects of inhaled glucocorticoids

A

Adrenal suppression
Oropharyngeal candidiasis
Dysphonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

averse effects of oral forms

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why is adrenal suppression an issue with glucocortcoid use

A

prolonged use of glucocorticoids can decrease the ability of the body to make its own endogenous glucocorticoids

  • periods of high stress, bpdy cannot produce glucocortcoids which is needed, patients will have to be given a higher dose of either oral or IV if this is the case
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Leukotriene Receptor Antagonists

A

Suppress effects of leukotrienes( promote smooth muscle constrictions , blood vessel permeability , and direct recruitment of inflammatory cells

considered second line agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how do leukotrine modifiers help patients with asthma ?

A

can reduce bronchoconstriction and inflammatory responses such as edema and mucous secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

problems with Leukotriene Receptor Antagonists

A

Generally well tolerated but can cause adverse neuropsychiatric effects, including depression, suicidal thinking, and suicidal behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Zileuton [Zyflo]
Zafirlukast [Accolate]
Montelukast [Singulair]

A

Leukotriene Receptor Antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is a mast cell stabilizer

A

Used for prophylaxis, not for quick relief
Suppresses inflammation; not a bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

mast cell stabilizer mechanism of action

A

Stabilizes cytoplasmic membrane of mast cells, thereby preventing release of histamine and other mediators; in addition, inhibits eosinophils, macrophages, and other inflammatory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

therapeutic use of mast cell stabilizer

A

Chronic asthma
Exercise-induced bronchospasm (EIB)
Allergic rhinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is a bronchodilator ?

A

symptomatic relief but do not alter the underlying disease process (inflammation)
principal bronchodilators are: beta2-adrenergic agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

patients that are also taking bronchodilators should also be taking what ?

A

glucocorticoid for long-term suppression of inflammation

25
Q

what do beta 2 adrenergic agonists do ?

A

activate the beta 2 receptors in the smooth muscle of the lungs , which will relieve the bronchospasm

Beta2 agonists have a limited role in suppressing histamine release in the lung and increasing ciliary motility

26
Q

What is a SABA

A

short acting beta 2 agonist use PRN to stop an ongoing attack taking place,
can be taken before exercise to prevent an attack

treatment of choice for an attack in the hospital
used with asthma and COPD

27
Q

what is a laba ?

A

Inhaled long-acting beta2 agonists

Long-term control in patients who experience frequent attacks
dosing is on fixed schedule —> NOT PRN

effective for stable COPD treatment

28
Q

using a LABA as treatment

A

When used to treat asthma, must always be combined with a glucocorticoid
contraindicted to treat asthma alone

29
Q

adverse effects of beta 2 agonists

A

inhaled : Tachycardia, angina, tremor
oral : Excessive dosage: Angina pectoris, tachydysrhythmias
Tremor

30
Q

what do anti cholinergic drugs do ?

A

Improves lung function by blocking muscarinic receptors in the bronchi, thereby reducing bronchoconstriction

31
Q

action and use of anticholinegic drugs

A

Improves lung function by blocking muscarinic receptors in the bronchi, thereby reducing bronchoconstriction

Therapeutic effects begin within 30 seconds, reach 50% of maximum in 3 minutes, and persist about 6 hours

32
Q

adverse effects of anticholinergic drugs

A

Dry mouth and irritation of the pharynx
Glaucoma
Cardiovascular events

33
Q

tiotropium and ipratropium

A

Long-acting, inhaled anticholinergic agent approved for maintenance therapy of bronchospasm associated with COPD

Not approved for asthma

34
Q

tiotropium works by

A

Relieves bronchospasm by blocking muscarinic receptors in the lung

35
Q

adverse effects of anticholinergic drugs

36
Q

LABA/ glucocorticoids

A

Indicated for long-term maintenance in adults and children
Not recommended for initial therapy

37
Q

management of chronic asthma

A

step wise therapy : Step chosen for initial therapy is based on pretreatment classification of asthma severity, moving up or own is based off of asthma control

38
Q

therapy for acute severe exacerbation

A

Oxygen—To relieve hypoxemia
A systemic glucocorticoid—To reduce airway inflammation
A nebulized, high-dose SABA—To relieve airflow obstruction
Nebulized ipratropium—To further reduce airflow obstruction

39
Q

management of copd 2 goals :

A

Reduce symptoms, thereby improving the patient’s health status and exercise tolerance

Reduce risks and mortality by preventing progression of COPD and by preventing and managing exacerbations

40
Q

pharmacological management of stable COPD

A

Bronchodilators
Glucocorticoids
Phosphodiesterase-4 inhibitors

41
Q

management of a copd exacerbation

A

SABAs (specifically inhaled, either alone or in combination with inhaled anticholinergics) are preferred for bronchodilation during COPD exacerbations
Systemic glucocorticoids
Supplemental oxygen to maintain an oxygen saturation of 88% to 92%

42
Q

what is allergic rhinitis ? symptoms ?

A

Inflammatory disorder of the upper airway, lower airway, and eyes

Sneezing
Rhinorrhea
Pruritus
Nasal congestion
For some people: Conjunctivitis, sinusitis, and asthma

43
Q

what is the pathophysiology of allergic rhinitis

A

Triggered by airborne allergens

Allergens bind to immunoglobulin E (IgE) on mast cells
Triggers release of inflammatory mediators
Histamine, leukotrienes, prostaglandins

44
Q

what kinds of drugs are used to treat rhinitis ?

A

Glucocorticoids (intranasal)
Antihistamines (oral and intranasal)
Sympathomimetics (oral and intranasal)

45
Q

first choice for treatment ? what are some of the side effects ?

A

FLONASE/Fluticasone , highly effective for prevention and treatment
has mild adverse effects- Drying of nasal mucosa or sore throat
Epistaxis (nosebleed)
Headache
Rarely, systemic effects (adrenal suppression and slowing of linear pediatric growth)

46
Q

oral antihistamines for rhinitis ? what are some of the adverse reactions ?

A

Does not reduce nasal congestion, effective when taken prophylactically and should be taken regularly when it is allergy season even with no symptoms

mild sedation will be seen with first gen medications and less is seen with second gen meds

47
Q

Intranasal Antihistamines: Azelastine and Olopatadine

A

treats rhinitis in kids over 12 and adults

48
Q

intra nasal antihistamine Systemic absorption can be sufficient to cause

A

somnolence
Nosebleeds
Anticholinergic effects
Unpleasant taste

49
Q

what does Intranasal Cromolyn Sodium do ?

A

Reduces symptoms by suppressing release of histamine and other inflammatory mediators from mast cells
Prophylaxis

50
Q

administering intranasal cromolyn

A

Administer before symptoms start
Response develops in 1 to 2 weeks
Minimal adverse reactions: Less than with any other drug for allergic rhinitis

51
Q

Sympathomimetics

A

Reduce nasal congestion (do not reduce rhinorrhea, sneezing, or itching, Activate alpha1-adrenergic receptors on nasal blood vessels

52
Q

adverse effects of Sympathomimetics

A

Rebound congestion
CNS stimulation
Cardiovascular effects and stroke
Abuse

53
Q

topical vs oral administration of Sympathomimetics

A

Topical agents act more quickly than oral agents and are usually more effective
Oral agents act longer than topical preparations
Systemic effects occur primarily with oral agents; topical agents usually elicit these responses only when dosage is higher than recommended

54
Q

rebound congestion will be commonly seen with

A

prolonged use of topical agents but not with oral agents

55
Q

Antihistamine-sympathomimetic combinations

A

Claritin D
Allegra D
Zyrtec D

56
Q

what is an antitussive ?

A

Drugs that suppress cough

57
Q

Nonopioid antitussives

A

Dextromethorphan
Diphenhydramine
Benzonatate

58
Q

opoid antitussive

A

Codeine and hydrocodone

59
Q

what are expectorants ?

A

Renders cough more productive by stimulating flow of respiratory tract secretions
ex) Guaifenesin [Mucinex, Humibid]